7Baggers
Quarterly
Annual
    Unit: USD2025-09-28 2025-06-29 2025-03-30 2024-12-29 2024-09-29 2024-06-30 2024-03-31 2023-12-31 2023-10-01 2023-07-02 2023-04-02 2023-01-01 2022-10-02 2022-07-03 2022-04-03 2022-01-02 2021-10-03 
      
    		                 
      cash flows (used for)/provided by operating activities:
    		                 
      net income
    		-20,131,000 -441,118,000 -33,405,000 -22,163,000 37,572,000 -4,931,000 -6,663,000 1,883,000 -40,258,000 84,000 1,644,000 -985,000 -11,840,000 -2,408,000 6,458,000 4,283,000 -3,752,000 
      adjustments to reconcile net (loss)/income to net cash (used for)/provided by operating activities:
    		                 
      depreciation and amortization expense
    		33,446,000 35,782,000 33,901,000 34,035,000 31,376,000 34,600,000 33,586,000 36,752,000 32,007,000 29,196,000 27,939,000 26,479,000 28,127,000 27,814,000 27,841,000 27,350,000 25,663,000 
      deferred and other income taxes
    		-6,611,000 -20,117,000 -10,668,000 3,089,000 5,316,000 -5,552,000 214,000           
      goodwill impairment
    		0                 
      other asset impairments and lease termination charges
    		4,805,000                 
      loss on disposal of property and equipment
    		          33,000    24,000 301,000  
      loss/(gain) on divestiture of insomnia cookies
    		                 
      gain on refranchising
    		                 
      gain on remeasurement of equity method investment
    		   0              
      gain on sale-leaseback
    		0       0 0 15,000 -9,661,000 -2,238,000 -1,937,000 0 -2,374,000   
      share-based compensation
    		774,000 4,634,000 2,603,000 10,546,000 9,969,000 7,648,000 6,986,000 6,375,000 7,452,000 4,824,000 5,545,000 4,852,000 2,825,000 5,452,000 5,041,000 5,950,000 6,315,000 
      change in accounts and notes receivable allowances
    		94,000 784,000 202,000 213,000 106,000 214,000 113,000 150,000 132,000 38,000 334,000 192,000 185,000 349,000 -156,000 142,000 23,000 
      inventory write-off
    		4,923,000 647,000 848,000 1,052,000 693,000 627,000 411,000 726,000 278,000 3,129,000 7,115,000 480,000 137,000 0 251,000 1,088,000 2,207,000 
      amortization related to settlement of interest rate swap derivatives
    		   0 0 -2,955,000 -2,955,000 -2,955,000 -2,955,000         
      other
    		-1,907,000 999,000 1,225,000 -882,000 -595,000 70,000 788,000 1,589,000 -430,000 1,200,000 -204,000 1,428,000 1,537,000 612,000 -1,345,000 909,000 110,000 
      change in operating assets and liabilities, excluding business acquisitions and divestitures, and foreign currency translation adjustments
    		                 
      net cash from operating activities
    		42,282,000 -32,543,000 -20,834,000 27,045,000 3,262,000 33,230,000 -17,705,000 1,512,000 -2,221,000 35,888,000 10,365,000 69,088,000 16,807,000 25,532,000 28,391,000 42,436,000 41,943,000 
      capex
    		-26,738,000 -28,209,000 -25,897,000 -33,915,000 -26,142,000 -31,671,000 -29,064,000 -32,822,000 -34,315,000 -27,737,000 -26,553,000 -36,715,000 -23,542,000 -22,000,000 -29,460,000 -36,012,000 -30,643,000 
      free cash flows
    		15,544,000 -60,752,000 -46,731,000 -6,870,000 -22,880,000 1,559,000 -46,769,000 -31,310,000 -36,536,000 8,151,000 -16,188,000 32,373,000 -6,735,000 3,532,000 -1,069,000 6,424,000 11,300,000 
      cash flows from investing activities:
    		                 
      purchase of property and equipment
    		-26,738,000 -28,209,000 -25,897,000 -33,915,000 -26,142,000 -31,671,000 -29,064,000 -32,822,000 -34,315,000 -27,737,000 -26,553,000 -36,715,000 -23,542,000 -22,000,000 -29,460,000 -36,012,000 -30,643,000 
      proceeds from sale-leaseback
    		0       0 0 0 10,025,000 2,701,000 2,700,000 0 3,000,000   
      acquisition of shops and franchise rights from franchisees, net of cash acquired
    		   -5,326,000        5,000    -12,442,000 0 
      purchase of equity method investment
    		-858,000   0 0       0      
      net proceeds from divestiture of insomnia cookies
    		0   6,480,000              
      principal payment received from loan to insomnia cookies
    		   0              
      principal payments received from loans to franchisees
    		0             14,000 15,000 25,000 22,000 
      disbursement for loan receivable
    		   0 0             
      other investing activities
    		78,000 13,000 86,000  14,000 147,000 19,000  -143,000 81,000 82,000       
      net cash from investing activities
    		  -25,811,000   -36,116,000 -29,045,000 -34,230,000 -34,256,000 -27,656,000 -16,446,000 -33,773,000 -39,422,000 -21,842,000 -26,437,000 -36,691,000 -30,455,000 
      cash flows provided by/(used for) financing activities:
    		                 
      proceeds from the issuance of debt
    		144,126,000 334,400,000 182,500,000 186,250,000 125,000,000 185,500,000 179,500,000 131,000,000 55,500,000 97,500,000 891,698,000 27,500,000 68,500,000 25,000,000 28,000,000 25,000,000 130,000,000 
      repayment of long-term debt and lease obligations
    		-120,687,000 -370,272,000 -115,622,000 -167,086,000 -238,895,000 -174,454,000 -132,343,000 -119,140,000 -48,670,000 -64,436,000 -852,144,000 -31,001,000 -20,001,000 -21,482,000 -28,697,000 -31,139,000 -574,557,000 
      payment of financing costs
    		0       -175,000 0 0 -5,000,000     0 0 
      proceeds from structured payables
    		44,298,000 79,144,000 118,908,000 77,638,000 108,389,000 88,875,000 101,287,000 96,049,000 71,160,000 29,182,000 44,757,000 62,564,000 66,362,000 78,917,000 74,180,000 71,924,000 54,329,000 
      payments on structured payables
    		-71,190,000 -56,360,000 -142,868,000 -80,981,000 -73,535,000 -93,395,000 -97,416,000 -55,003,000 -32,651,000 -56,440,000 -70,480,000 -82,679,000 -78,248,000 -75,169,000 -58,361,000 -64,562,000 -84,963,000 
      capital contribution by shareholders, net of loans issued
    		    0 687,000 232,000  0   0 -261,000     
      proceeds from sale of noncontrolling interest in subsidiary
    		   1,198,000        183,000 0 358,000 52,000 67,000 81,000 
      distribution to shareholders
    		0 -5,973,000 -5,961,000 -5,949,000 -5,936,000 -5,905,000 -5,902,000 -5,901,000 -5,886,000 -5,887,000 -5,884,000 -5,860,000 -5,860,000 -5,855,000 -5,855,000 -5,853,000 -7,970,000 
      payments for repurchase and retirement of common stock
    		-397,000 -664,000 -123,000 -1,123,000 -91,000 -3,471,000 -804,000 -271,000 -1,462,000   -1,594,000 -62,000 -897,000 -1,466,000 -602,000 -35,803,000 
      distribution to noncontrolling interest
    		0 0 -36,000 -6,548,000 -32,889,000 -1,169,000 -977,000 -2,655,000 -1,637,000 -10,107,000 -1,139,000 -196,000 -2,029,000 -8,134,000 -1,362,000 -6,099,000 -11,239,000 
      net cash provided by/(used for) financing activities
    		          1,808,000       
      effect of exchange rate changes on cash, cash equivalents and restricted cash
    		-1,585,000 -999,000 -301,000 -1,548,000 1,201,000 1,714,000 -1,829,000 862,000 215,000 -1,638,000 -1,373,000 2,999,000 -3,494,000 -2,245,000 -2,228,000 -377,000 -666,000 
      net increase/(decrease) in cash, cash equivalents and restricted cash
    		                 
      cash, cash equivalents and restricted cash at beginning of period
    		0 0 29,315,000  0 0 38,614,000  0 0 35,730,000  0 0 39,192,000  0 
      cash, cash equivalents and restricted cash at end of period
    		9,329,000 2,656,000 19,167,000  -3,224,000 -4,504,000 33,612,000  -833,000 -3,110,000 30,084,000  2,292,000 -6,084,000 32,291,000  7,629,000 
      supplemental schedule of non-cash investing and financing activities:
    		                 
      (decrease)/increase in accrual for property and equipment
    		          -104,000       
      accrual for distribution to shareholders
    		  -5,960,000 -9,000 -24,000 -14,000 -5,905,000 -1,000 -15,000 -2,000 -5,884,000 -24,000 0 -5,000 -5,855,000 -1,075,000 2,117,000 
      reconciliation of cash, cash equivalents and restricted cash at end of period:
    		                 
      cash and cash equivalents
    		9,443,000 2,542,000 18,722,000 3,552,000 -3,215,000 -4,507,000 33,132,000 12,474,000 -924,000 -3,040,000 29,675,000 7,275,000 2,300,000 -5,819,000 31,615,000 -6,333,000 7,518,000 
      restricted cash
    		-114,000 114,000 445,000 -121,000 -9,000 3,000 480,000 -1,000 91,000 -70,000 409,000 -44,000 -8,000 -265,000 676,000 437,000 111,000 
      total cash, cash equivalents and restricted cash
    		9,329,000 2,656,000 19,167,000 3,431,000 -3,224,000 -4,504,000 33,612,000 12,473,000 -833,000 -3,110,000 30,084,000 7,231,000 2,292,000 -6,084,000 32,291,000 -5,896,000 7,629,000 
      adjustments to reconcile net income to net cash (used for)/provided by operating activities:
    		                 
      loss/(gain) on disposal of property and equipment
    		 214,000 189,000               
      loss on divestiture of insomnia cookies
    		                 
      change in operating assets and liabilities, excluding foreign currency translation adjustments
    		 -26,052,000 -15,891,000   3,262,000 -50,383,000   10,581,000 -35,190,000       
      cash flows provided by/(used for) investing activities:
    		                 
      net cash provided by/(used for) investing activities
    		   -25,465,000              
      cash flows from financing activities:
    		                 
      net cash from financing activities
    		 -20,550,000 36,798,000    43,577,000  35,429,000       -11,264,000 -3,193,000 
      net decrease in cash, cash equivalents and restricted cash
    		 2,656,000 -10,148,000  -3,224,000 -4,504,000 -5,002,000  -833,000 -3,110,000 -5,646,000       
      increase in accrual for property and equipment
    		 5,500,000 4,812,000 1,852,000 186,000    19,980,000    11,773,000 -990,000 5,489,000   
      cash flows used for operating activities:
    		                 
      adjustments to reconcile net income to net cash from operating activities:
    		                 
      impairment and lease termination charges
    		  162,000 4,096,000 -80,000 201,000 247,000 17,198,000 -97,000 2,908,000 4,900,000 11,042,000 5,264,000 1,773,000 218,000 2,653,000 -272,000 
      cash flows used for investing activities:
    		                 
      cash flows from operating activities:
    		                 
      adjustments to reconcile net income/(loss) to net cash from operating activities:
    		                 
      loss on extinguishment of debt
    		       0 0 0 472,000     0 0 
      gain on divestiture of insomnia cookies
    		   -3,327,000              
      settlement of interest rate swap derivatives
    		       0 0 0 7,657,000       
      change in operating assets and liabilities, excluding business acquisitions and divestitures, and foreign currency translation adjustments:
    		                 
      accounts, notes, and taxes receivable
    		                 
      inventories
    		                 
      other current and noncurrent assets
    		                 
      operating lease assets and liabilities
    		                 
      accounts payable and accrued liabilities
    		                 
      other long-term obligations and deferred credits
    		                 
      proceeds from disposals of assets
    		       16,000    221,000 -16,000 864,000 8,000 16,000 55,000 
      cash flows (used for)/provided by financing activities:
    		                 
      payment of contingent consideration related to a business combination
    		       0    0 0 0 -900,000   
      capital contribution from shareholders, net of loans issued
    		                 
      payments of issuance costs in connection with initial public offering
    		                 
      net cash (used for)/provided by financing activities
    		   3,399,000          -7,529,000 -6,627,000   
      net (decrease)/increase in cash, cash equivalents and restricted cash
    		           7,231,000   -6,901,000   
      cash, cash equivalents and restricted cash at beginning of the fiscal year
    		                 
      cash, cash equivalents and restricted cash at end of the fiscal year
    		                 
      stock issuance under shareholder notes
    		           67,000 223,000 133,000 191,000 517,000 0 
      reconciliation of cash, cash equivalents and restricted cash at end of fiscal year:
    		                 
      note 1
    		                 
      note 2
    		                 
      note 3
    		                 
      note 4
    		                 
      note 5
    		                 
      note 6
    		                 
      note 7
    		                 
      note 8
    		                 
      note 9
    		                 
      note 10
    		                 
      note 11
    		                 
      note 12
    		                 
      note 13
    		                 
      note 14
    		                 
      note 15
    		                 
      note 16
    		                 
      note 17
    		                 
      note 18
    		                 
      note 19
    		                 
      note 20
    		                 
      adjustments to reconcile net (loss)/income to net cash from operating activities:
    		                 
      gain on disposal of property and equipment
    		        -17,000         
      cash flows from/(used for) financing activities:
    		                 
      cash flows (used for)/from operating activities:
    		                 
      (gain)/loss on disposal of property and equipment
    		      -49,000      255,000     
      increase/(decrease) in accrual for property and equipment
    		      3,913,000           
      change in operating assets and liabilities, excluding business acquisitions and foreign currency translation adjustments:
    		                 
      maturities of held-to-maturity debt securities
    		               631,000 111,000 
      proceeds from ipo, net of underwriting discounts
    		               0  
      payments of issuance costs in connection with ipo
    		           0 0 0 -12,458,000   
      deferred income taxes
    		        24,377,000 -11,524,000 -219,000  -3,393,000 -6,044,000 -822,000 -12,664,000 1,173,000 
      change in operating assets and liabilities, excluding business acquisitions and foreign currency translation adjustments
    		            -4,353,000 -1,493,000 -6,745,000   
      cash flows used for financing activities:
    		                 
      capital contribution by shareholders
    		              240,000 0 -400,000 
      gain on contingent consideration related to a business combination
    		                 
      purchases of held-to-maturity debt securities
    		                 
      cash flows (used for)/from financing activities:
    		                 
      accrual for repurchase and retirement of common stock
    		                35,615,000 
      accrual for distribution to noncontrolling interest
    		                 
      common stock issuance under subscription receivable in connection with initial public offering, net of underwriting discounts and issuance costs
    		                 
      payment of contingent consideration in excess of acquisition date fair value
    		                 
      collection of related party income tax receivable
    		                 
      contingent consideration incurred for acquisition of krispy kreme mexico
    		                 
      contingent consideration incurred for acquisition of shops and franchise rights from domestic franchisees
    		                 
      net increase in cash, cash equivalents and restricted cash
    		                 
      accrual for property and equipment
    		                1,756,000 
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.